Tevogen Inc. Common Stock
TVGN
4 hedge funds and large institutions have $51.6M invested in Tevogen Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 61 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.3% less ownership
Funds ownership: 1.9% → 0.61% (-1.3%)
85% less capital invested
Capital invested by funds: $353M → $51.6M (-$302M)
94% less funds holding
Funds holding: 64 → 4 (-60)
98% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 61
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$1.59M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$33.5M |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
-$20.7M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$18.8M |
| 4 |
Millennium Management
New York
|
-$17.8M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$15.4M |
TVGN Hedge Fund Activity: Q1 2023 in Review
4 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q1 2023, worth a combined $51.6M — down 85% from $353M a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of TVGN and 1 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $1.59M. The largest seller was Saba Capital Management, exiting entirely with an estimated $33.5M sold.
- 4 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q1 2023, down from 64 in Q4 2022.
- Funds reported $51.6M of Tevogen Inc. Common Stock stock for Q1 2023, down 85% quarter-over-quarter.
- 1 fund opened new Tevogen Inc. Common Stock positions in Q1 2023 and 61 closed out, a net change of -60 holders.
- The largest Tevogen Inc. Common Stock buyer in Q1 2023 was Cantor Fitzgerald, an estimated $1.59M added.
- The largest Tevogen Inc. Common Stock seller in Q1 2023 was Saba Capital Management, an estimated $33.5M sold.
Based on aggregated 13F filings for Q1 2023.